Drugs / C19-A3 GNP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02837094 | Sep 2016 → Dec 2019 | type 1 diabetes mellitus | Cardiff University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | C19-A3 GNP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02837094 ↗ |
| Route | Other | “intradermal administration of C19-A3 GNP” PMID 35919496 ↗ Jan 2022 |